Literature DB >> 2612118

Serum osteocalcin as an index of bone turnover in active rheumatoid arthritis and in active psoriatic arthritis.

M Magarò1, L Altomonte, L Mirone, A Zoli, A Tricerri.   

Abstract

Juxtaarticular osteoporosis is a recognized clinical feature in both rheumatoid arthritis (RA) and psoriatic arthritis (PA), while generalised osteopenia seems to be characteristic of RA only. To assess differences in bone turnover in the two forms of disease, we measured serum osteocalcin levels and other parameters of bone metabolism in two groups of female, ambulant, age-matched patients suffering from active RA or active PA and never treated with steroid therapy. Serum osteocalcin levels were significantly higher in RA patients than in PA patients (13.05 +/- 1.27 ng/ml vs 4.83 +/- 0.88 ng/ml; p less than 0.001), with a significant positive correlation between osteocalcin and serum alkaline phosphatase in both groups. These data suggest that bone turnover is higher in active RA than in active PA. Juxtaarticular osteoporosis could be mediated by local disease mechanisms both in RA and in PA, while factors specifically related to active RA seem to determine a more generalized impairment of bone turnover.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612118     DOI: 10.1007/bf02032102

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  15 in total

1.  Psoriatic arthritis. A comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis.

Authors:  V WRIGHT
Journal:  Ann Rheum Dis       Date:  1961-06       Impact factor: 19.103

2.  Therapeutic criteria in rheumatoid arthritis.

Authors:  O STEINBROCKER; C H TRAEGER; R C BATTERMAN
Journal:  J Am Med Assoc       Date:  1949-06-25

3.  Osteoporosis in rheumatoid arthritis. A follow-up study.

Authors:  P Virtama; T Helelä; J L Kalliomäki
Journal:  Acta Rheumatol Scand       Date:  1968

4.  Osteoporosis in rheumatoid arthritis.

Authors:  A O Bjelle; B E Nilsson
Journal:  Calcif Tissue Res       Date:  1970

5.  In vitro degradation of bone particles by human monocytes is decreased with the depletion of the vitamin K-dependent bone protein from the matrix.

Authors:  J B Lian; K Dunn; L L Key
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

6.  Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis.

Authors:  D M Reid; N S Kennedy; J Nicoll; M A Smith; P Tothill; G Nuki
Journal:  Clin Rheumatol       Date:  1986-09       Impact factor: 2.980

7.  Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting.

Authors:  D M Slovik; C M Gundberg; R M Neer; J B Lian
Journal:  J Clin Endocrinol Metab       Date:  1984-08       Impact factor: 5.958

8.  Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements.

Authors:  D M Reid; N S Kennedy; M A Smith; J Nicoll; N Brown; P Tothill; G Nuki
Journal:  Br J Rheumatol       Date:  1986-08

9.  Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein.

Authors:  P D Delmas; H W Wahner; K G Mann; B L Riggs
Journal:  J Lab Clin Med       Date:  1983-10

10.  Changes in plasma bone GLA protein during treatment of bone disease.

Authors:  L J Deftos; J G Parthemore; P A Price
Journal:  Calcif Tissue Int       Date:  1982-03       Impact factor: 4.333

View more
  3 in total

1.  Bone mineral density and bone turnover in patients with psoriatic arthritis.

Authors:  Pinar Borman; Seçil Babaoğlu; Guneş Gur; Sezin Bingol; Hatice Bodur
Journal:  Clin Rheumatol       Date:  2007-09-18       Impact factor: 2.980

2.  Effect of Vitamin D on Peripheral Blood Mononuclear Cells from Patients with Psoriasis Vulgaris and Psoriatic Arthritis.

Authors:  Susana Cubillos; Nadine Krieg; Johannes Norgauer
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

3.  Mediators of inflammation-induced bone damage in arthritis and their control by herbal products.

Authors:  Siddaraju M Nanjundaiah; Brian Astry; Kamal D Moudgil
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-07       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.